PMID- 18383428 OWN - NLM STAT- MEDLINE DCOM- 20081027 LR - 20220309 IS - 1099-1557 (Electronic) IS - 1053-8569 (Linking) VI - 17 IP - 8 DP - 2008 Aug TI - The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. PG - 822-33 LID - 10.1002/pds.1592 [doi] AB - PURPOSE: To describe the nationwide pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) in the Danish population. METHODS: All Danish citizens aged 10 or above 1 January 1997 were included in the study. The national prescription registry was used to identify all claimed prescriptions for NSAIDs by the cohort until 2005. By individual-level-linkage of nationwide registries, information was acquired concerning hospitalizations, comorbidity, concomitant pharmacotherapy and socioeconomic factors. RESULTS: The population consisted of 4,614,807 individuals, of which 2,663,706 (57.8%) claimed at least one prescription for NSAID from 1997 to 2005. Ibuprofen and diclofenac were the most frequently used non-selective NSAIDs, whereas rofecoxib and celecoxib were the most frequently used selective cyclooxygenase-2 (COX-2) inhibitors. The usage was similar across all age groups. Female sex and increasing age was associated with increased use of NSAID. Factors predicting extensive NSAID use were: rheumatic disease (odds ratio (OR) = 1.79, 95% confidence interval (CI): 1.69-1.90), gout agents (allopurinol) (OR = 2.54, CI: 2.44-2.64) and other pain medication (OR = 3.27, CI: 3.23-3.31). NSAIDs were most often prescribed for use for one distinct treatment interval and for a short period (overall inter-quartile range [IQR]: 9-66 days). High doses were used in a relatively large proportion of the population (8.9% for etodolac to 19.5% for celecoxib) and 54,373 (2.0%) claimed prescriptions for more than one NSAID at the same time. CONCLUSION: NSAIDs were commonly used in the Danish population. Since NSAIDs have been associated with increased cardiovascular risk, further research on the overall risk associated with these drugs on a national scale is needed. FAU - Fosbol, Emil Loldrup AU - Fosbol EL AD - Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark. elf@heart.dk FAU - Gislason, Gunnar H AU - Gislason GH FAU - Jacobsen, Soren AU - Jacobsen S FAU - Abildstrom, Steen Z AU - Abildstrom SZ FAU - Hansen, Morten Lock AU - Hansen ML FAU - Schramm, Tina Ken AU - Schramm TK FAU - Folke, Fredrik AU - Folke F FAU - Sorensen, Rikke AU - Sorensen R FAU - Rasmussen, Jeppe N AU - Rasmussen JN FAU - Kober, Lars AU - Kober L FAU - Madsen, Mette AU - Madsen M FAU - Torp-Pedersen, Christian AU - Torp-Pedersen C LA - eng PT - Journal Article PL - England TA - Pharmacoepidemiol Drug Saf JT - Pharmacoepidemiology and drug safety JID - 9208369 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use MH - Child MH - Denmark MH - Drug Utilization/*trends MH - Female MH - Humans MH - Logistic Models MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Odds Ratio MH - Time Factors EDAT- 2008/04/03 09:00 MHDA- 2008/10/28 09:00 CRDT- 2008/04/03 09:00 PHST- 2008/04/03 09:00 [pubmed] PHST- 2008/10/28 09:00 [medline] PHST- 2008/04/03 09:00 [entrez] AID - 10.1002/pds.1592 [doi] PST - ppublish SO - Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):822-33. doi: 10.1002/pds.1592.